
Keywords: ALLO, Allopregnanolone; GABAA, γ-aminobutyric acid type A; NMDA, N-methyl-d-aspartate; SP, substance P; CGPR, calcitonin gene-related peptide; KOR, kappa opioid receptor; DOR, delta opioid receptor; MOR, mu opioid receptor; DHEA, dehydroepiandrosterone; D